|
Delayed
London S.E.
12:36:10 07/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.1450 GBX | +3.57% |
|
0.00% | -56.72% |
| 10/08 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 10/08 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
| Market Cap | 18.48L 24.99L 21.51L 20.23L 34.58L 24Cr 34.67L 2.39Cr 92.78L 12Cr 93.85L 91.8L 39Cr | P/E 2024 |
-0.53x | P/E 2025 | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 10.58L 14.31L 12.31L 11.58L 19.8L 14Cr 19.85L 1.37Cr 53.12L 6.93Cr 53.73L 52.56L 22Cr | EV / Sales 2024 |
2,72,64,249x | EV / Sales 2025 | 5,41,21,446x |
| Free-Float |
91.05% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| VAL | Delayed | |
Deutsche Boerse AG
| EAJF | Delayed | |
|
Börse Stuttgart
| EAJF | Delayed |
| 1 day | +3.57% | ||
| Current month | -6.45% | ||
| 1 month | -9.38% | ||
| 3 months | -19.44% | ||
| 6 months | -52.46% | ||
| Current year | -56.72% |
| 1 week | 0.13 |  | 0.16 |
| 1 month | 0.13 | | 0.17 |
| Current year | 0.13 | | 0.48 |
| 1 year | 0.13 | | 0.8 |
| 3 years | 0.13 | | 15 |
| 5 years | 0.13 | | 65 |
| 10 years | 0.13 | | 1,436.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Eccleston
CEO | Chief Executive Officer | 55 | 12/08/2024 |
Gerald Desler
DFI | Director of Finance/CFO | 81 | - |
Michelle Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 27/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerald Desler
BRD | Director/Board Member | 81 | 01/09/2006 |
| Chairman | 60 | 25/07/2024 | |
Mark Eccleston
BRD | Director/Board Member | 55 | 12/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/03/26 | Buy | Chief Executive Officer | 10,00,000 | 0.1346% | ||
| 18/10/22 | Free | Director | 75,000 | 0.0832% | ||
| 18/10/22 | Free | Director | 75,000 | 0.0832% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.57% | 0.00% | -80.67% | -97.80% | 24.99L | |
| -1.79% | -2.27% | +43.23% | +99.78% | 6.8TCr | |
| -3.40% | -1.42% | +33.13% | +80.13% | 6.49TCr | |
| -0.31% | +6.54% | -12.96% | +377.83% | 2.76TCr | |
| +0.86% | +1.65% | -7.74% | -13.58% | 2.61TCr | |
| -1.42% | -0.74% | +24.37% | +15.84% | 2.57TCr | |
| -0.74% | +1.18% | +23.46% | -18.27% | 2.01TCr | |
| -2.96% | -15.21% | +216.20% | +375.70% | 1.72TCr | |
| +0.20% | -1.37% | -6.86% | +549.54% | 1.49TCr | |
| -0.20% | +8.37% | +55.78% | +165.57% | 1.46TCr | |
| Average | -0.62% | -0.74% | +28.79% | +153.47% | 2.79TCr | |
| Weighted average by Cap. | -1.54% | +0.18% | +36.02% | +140.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.05 0.07 0.06 0.05 0.09 6.35 0.09 0.64 0.25 3.26 0.25 0.25 10.5 | 0.03 0.04 0.04 0.03 0.06 4 0.06 0.41 0.16 2.05 0.16 0.16 6.62 |
| Net income | -19.16L -25.9L -22.29L -20.97L -35.84L -24Cr -35.93L -2.48Cr -96.16L -13Cr -97.27L -95.14L -40Cr | -22.32L -30.18L -25.97L -24.44L -41.76L -28Cr -41.87L -2.89Cr -1.12Cr -15Cr -1.13Cr -1.11Cr -47Cr |
| Net Debt | -15.44L -20.88L -17.97L -16.9L -28.89L -20Cr -28.96L -2Cr -77.51L -10Cr -78.4L -76.69L -33Cr | -8L -10.68L -9L -9L -14.78L -10Cr -14.82L -1.02Cr -39.67L -5.18Cr -40.12L -39.25L -17Cr |
Employees
11
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | GBX 0.1450 | +3.57% | 50,00,000 |
| 04/26/04 | GBX 0.1400 | 0.00% | 13,27,913 |
| 03/26/03 | GBX 0.1400 | 0.00% | 2,00,32,318 |
| 02/26/02 | GBX 0.1400 | -3.45% | 27,86,069 |
| 01/26/01 | GBX 0.1450 | -6.45% | 1,69,76,047 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VAL Stock
Select your edition
All financial news and data tailored to specific country editions
